HYDROCHLOROTHIAZIDE
- Product NDC
- 68071-5284
- Requested package NDC
- 68071-5284-1
- 11-digit product format
- 680715284
- Labeler code
- 68071
- Product ID
- 68071-5284_dfc93cb0-dd47-7d7e-e053-2a95a90a5ef1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA085182
- Marketing category
- ANDA
- Marketing start
- 2015-01-15
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 68071-5284 | 68071-5284-1 | D | Discontinued by firm | 2026-08-11 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A085182-001 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | |
| A085182-002 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | |
| A085182-003 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A085182-001 | AB |
| A085182-002 | AB |
| A085182-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A085182-002 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | Approved before 1982 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A085182-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2023-05-02 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A085182-001 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | Approved before 1982 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A085182-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A085182-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A085182-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085182-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085182-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085182-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A085182-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A085182-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A085182-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085182-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085182-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085182-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085182-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085182-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085182-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085182-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085182-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085182-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085182-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085182-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085182-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085182-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085182-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085182-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085182-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085182-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085182-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A085182-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A085182-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A085182-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085182-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085182-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085182-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085182-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085182-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085182-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A085182-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A085182-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A085182-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A085182-001 | AB | 1 | 8072bd15b7f6… |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-5284-1 | 2022-05-25 | C162847 | 48780-1 | d6a99b39-74de-a426-e053-dadaa90af4c2 | HYDROCHLOROTHIAZIDE TABLETS, USP Rx only |
| 68071-5284-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-74de-a426-e053-dadaa90af4c2 | HYDROCHLOROTHIAZIDE TABLETS, USP Rx only |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 31a3d1cb-0f52-4818-965d-7584374bb23e | 2026-08-06 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 5ab641d8-cd22-4368-8070-18487dd801eb | 2026-05-11 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 686a5743-adc9-4729-9dbf-5cbc2c23897a | 2026-01-19 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | c8c79657-a09a-bdb6-e053-2995a90ab673 | 2026-01-01 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | 076017ce-8aad-1336-e063-6394a90a76b5 | 2025-12-26 | Warnings, Adverse reactions | 085182 ANDA085182 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Chartwell RX, LLC | 4e43dd27-3f4b-4205-a26e-6ecaa8281347 | 2025-12-10 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | QPharma Inc | f795db5e-d5ef-4a20-e053-6394a90a7fda | 2025-12-03 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 1fad059f-f030-4dd8-b02a-bf3e775d37d2 | 2025-11-28 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 67c48f86-f412-4957-8e15-aec89e07d295 | 2025-11-18 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 42542233-b992-4953-87ec-5095b196d61b | 2025-11-18 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | c59c4230-7cea-4259-9f2f-6a568716fedf | 2025-06-02 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 1570f1ad-8372-477f-89c3-8c9ce01e27d1 | 2025-05-07 | Warnings, Adverse reactions | 085182 ANDA085182 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | a111cb8f-a100-a05d-e053-2995a90a020c | 2024-06-20 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 5605f105-f7ec-473f-8beb-9e8955e8e26e | 2023-04-28 | Warnings, Adverse reactions | 085182 ANDA085182 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 3464be28-5bab-4642-9d9b-8b425822dd07 | 2023-04-01 | Warnings, Adverse reactions | 085182 ANDA085182 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-5284-1 | 68071528401 | 100 TABLET in 1 BOTTLE (68071-5284-1) | 100 tablet | 2020-06-18 | 0000-00-00 | No | No | Current |